back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2016-05-16 Tx date 2016-05-12 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Chai-Onn, Robert Roswell
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$1,513,176
+60,697 vol $24.93 each |
62,375 | |
| Filed 2015-10-22 Tx date 2015-10-20 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Chai-Onn, Robert Roswell
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$246,082
+1,677 vol $146.74 each |
63,316 | |
| Filed 2015-10-22 Tx date 2015-10-20 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Chai-Onn, Robert Roswell
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-128,544.24
-876 vol $146.74 each |
62,440 | |
| Filed 2015-10-22 Tx date 2015-10-20 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Chai-Onn, Robert Roswell
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-246,082.98
-1,677 vol $146.74 each |
1,678 | |
| Filed 2015-05-06 Tx date 2015-05-04 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Chai-Onn, Robert Roswell
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,311,643
+90,938 vol $25.42 each |
130,770 | |
| Filed 2015-05-06 Tx date 2015-05-05 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Chai-Onn, Robert Roswell
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-133,022.70
-21,807 vol $6.10 each |
306,157 | |
| Filed 2015-05-06 Tx date 2015-05-04 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Chai-Onn, Robert Roswell
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,237,442.5518
-90,938 vol $222.54 each |
39,832 | |
| Filed 2015-05-06 Tx date 2015-05-05 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Chai-Onn, Robert Roswell
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$133,022
+21,807 vol $6.10 each |
61,639 | |
| Filed 2015-05-06 Tx date 2015-05-04 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Chai-Onn, Robert Roswell
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-20,237,442.5518
-90,938 vol $222.54 each |
327,964 |